NASDAQ: SNSE - Sensei Biotherapeutics, Inc.

Altı ay boyunca karlılık: -20.96%
Sektör: Healthcare

Promosyon programı Sensei Biotherapeutics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors.

daha fazla ayrıntı
It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

EBITDA -0.0124
EV/EBITDA -1.28
IPO date 2021-02-04
ISIN US81728A1088
Industry Biotechnology
P/BV 1
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.senseibio.com
Цена ао 1.04
Число акций ао 0.02795 млрд
Günlük fiyat değişimi: +3.92% (0.4792)
Haftalık fiyat değişimi: +10.69% (0.4499)
Aylık fiyat değişimi: -10.35% (0.5555)
3 ayda fiyat değişimi: -10.35% (0.5555)
Altı ayda fiyat değişimi: -20.96% (0.6301)
Yıllık fiyat değişimi: -28.03% (0.692)
3 yılda fiyat değişimi: -91.31% (5.73)
5 yılda fiyat değişimi: 0% (0.498)
10 yılda fiyat değişimi: 0% (0.498)
Yılbaşından bu yana fiyat değişimi: +9.67% (0.4541)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 0.2886 10
P/E 0 0
EV/EBITDA -0.3268 0
Toplam: 3.75

Yeterlik

İsim Anlam Seviye
ROA, % -45.85 0
ROE, % -52.55 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.1701 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 169.24 10
karlılık EPS, % -20.78 0
Toplam: 5.6
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Newtyn Management, LLC 1572023 6.27
Vanguard Group Inc 573651 2.29
Renaissance Technologies, LLC 143508 0.57
Geode Capital Management, LLC 136318 0.54
Bridgeway Capital Management, Inc. 112900 0.45
Duquesne Family Office LLC 100000 0.4
Bank of America Corporation 90788 0.36
Millennium Management LLC 38295 0.15
Blackrock Inc. 34813 0.14
Northern Trust Corporation 26049 0.1



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. John K. Celebi M.B.A. President, CEO & Director 882.28k 1972 (53 yıl)
Dr. Edward Van der Horst Ph.D. Chief Scientific Officer 630.81k 1974 (51 yıl)
Ms. Lora Pike Vice President of Investor Relations & Communications N/A
Mr. Christopher W. Gerry J.D. Senior VP, General Counsel & Secretary N/A
Ms. Stephanie Krebs M.B.A., M.S. Chief Business Officer N/A 1978 (47 yıllar)
Dr. Aaron Weitzman FACP, M.D., Ph.D. Chief Medical Officer N/A
Mr. Josiah Craver Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer

Adres: United States, Rockville. MD, 1405 Research Boulevard - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.senseibio.com